AVANTIUM (AVTX.AS) Fundamental Analysis & Valuation

AMS:AVTX • NL0015002IE0

Current stock price

6.79 EUR
+0.06 (+0.91%)
Last:

This AVTX.AS fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

1

1. AVTX.AS Profitability Analysis

1.1 Basic Checks

  • AVTX had negative earnings in the past year.
  • In the past year AVTX has reported a negative cash flow from operations.
  • AVTX had negative earnings in each of the past 5 years.
  • In the past 5 years AVTX always reported negative operating cash flow.
AVTX.AS Yearly Net Income VS EBIT VS OCF VS FCFAVTX.AS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -50M -100M

1.2 Ratios

  • AVTX has a worse Return On Assets (-6.32%) than 77.42% of its industry peers.
  • AVTX has a Return On Equity of -14.76%. This is in the lower half of the industry: AVTX underperforms 77.42% of its industry peers.
Industry RankSector Rank
ROA -6.32%
ROE -14.76%
ROIC N/A
ROA(3y)-9.79%
ROA(5y)-15.6%
ROE(3y)-36.93%
ROE(5y)-38.73%
ROIC(3y)N/A
ROIC(5y)N/A
AVTX.AS Yearly ROA, ROE, ROICAVTX.AS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 50 -50

1.3 Margins

  • AVTX has a Gross Margin of 77.17%. This is in the better half of the industry: AVTX outperforms 74.19% of its industry peers.
  • AVTX's Gross Margin has been stable in the last couple of years.
  • The Profit Margin and Operating Margin are not available for AVTX so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 77.17%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.33%
GM growth 5Y-0.67%
AVTX.AS Yearly Profit, Operating, Gross MarginsAVTX.AS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 200 -200 -400 -600

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

2

2. AVTX.AS Health Analysis

2.1 Basic Checks

  • AVTX does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • The number of shares outstanding for AVTX has been increased compared to 1 year ago.
  • AVTX has more shares outstanding than it did 5 years ago.
  • AVTX has a better debt/assets ratio than last year.
AVTX.AS Yearly Shares OutstandingAVTX.AS Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5M 10M 15M 20M 25M
AVTX.AS Yearly Total Debt VS Total AssetsAVTX.AS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M

2.2 Solvency

  • AVTX has an Altman-Z score of -1.21. This is a bad value and indicates that AVTX is not financially healthy and even has some risk of bankruptcy.
  • Looking at the Altman-Z score, with a value of -1.21, AVTX is doing worse than 93.55% of the companies in the same industry.
  • AVTX has a Debt/Equity ratio of 0.30. This is a healthy value indicating a solid balance between debt and equity.
  • AVTX's Debt to Equity ratio of 0.30 is amongst the best of the industry. AVTX outperforms 87.10% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.3
Debt/FCF N/A
Altman-Z -1.21
ROIC/WACCN/A
WACC6.96%
AVTX.AS Yearly LT Debt VS Equity VS FCFAVTX.AS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 50M -50M 100M -100M 150M

2.3 Liquidity

  • A Current Ratio of 0.46 indicates that AVTX may have some problems paying its short term obligations.
  • The Current ratio of AVTX (0.46) is worse than 90.32% of its industry peers.
  • A Quick Ratio of 0.45 indicates that AVTX may have some problems paying its short term obligations.
  • With a Quick ratio value of 0.45, AVTX is not doing good in the industry: 83.87% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 0.46
Quick Ratio 0.45
AVTX.AS Yearly Current Assets VS Current LiabilitesAVTX.AS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

5

3. AVTX.AS Growth Analysis

3.1 Past

  • AVTX shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 25.49%, which is quite impressive.
  • The Revenue for AVTX has decreased by -30.63% in the past year. This is quite bad
  • Measured over the past years, AVTX shows a quite strong growth in Revenue. The Revenue has been growing by 8.15% on average per year.
EPS 1Y (TTM)25.49%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%12.08%
Revenue 1Y (TTM)-30.63%
Revenue growth 3Y-6.45%
Revenue growth 5Y8.15%
Sales Q2Q%-34.54%

3.2 Future

  • Based on estimates for the next years, AVTX will show a quite strong growth in Earnings Per Share. The EPS will grow by 12.58% on average per year.
  • Based on estimates for the next years, AVTX will show a very strong growth in Revenue. The Revenue will grow by 59.63% on average per year.
EPS Next Y52.28%
EPS Next 2Y33.16%
EPS Next 3Y9.98%
EPS Next 5Y12.58%
Revenue Next Year106.79%
Revenue Next 2Y76.47%
Revenue Next 3Y59.71%
Revenue Next 5Y59.63%

3.3 Evolution

  • The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
AVTX.AS Yearly Revenue VS EstimatesAVTX.AS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 50M 100M 150M 200M 250M
AVTX.AS Yearly EPS VS EstimatesAVTX.AS Yearly EPS VS EstimatesYearly EPS VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 -1 -2 -3 -4 -5

More info and screens

Find the best growth stocksShow best growing peers

0

4. AVTX.AS Valuation Analysis

4.1 Price/Earnings Ratio

  • AVTX reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • Also next year AVTX is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
AVTX.AS Price Earnings VS Forward Price EarningsAVTX.AS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
AVTX.AS Per share dataAVTX.AS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y33.16%
EPS Next 3Y9.98%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. AVTX.AS Dividend Analysis

5.1 Amount

  • No dividends for AVTX!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

AVTX.AS Fundamentals: All Metrics, Ratios and Statistics

AVANTIUM

AMS:AVTX (4/2/2026, 7:00:00 PM)

6.79

+0.06 (+0.91%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCommercial & Professional Services
GICS IndustryProfessional Services
Earnings (Last)03-18
Earnings (Next)N/A
Inst Owners2.89%
Inst Owner ChangeN/A
Ins Owners1.85%
Ins Owner ChangeN/A
Market Cap171.18M
Revenue(TTM)14.59M
Net Income(TTM)-22.52M
Analysts80
Price Target25.93 (281.89%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-2.87%
PT rev (3m)-1.14%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-4.8%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 11.73
P/FCF N/A
P/OCF N/A
P/B 1.12
P/tB 1.14
EV/EBITDA N/A
EPS(TTM)-1.69
EYN/A
EPS(NY)-1.8
Fwd EYN/A
FCF(TTM)-1.92
FCFYN/A
OCF(TTM)-1.1
OCFYN/A
SpS0.58
BVpS6.05
TBVpS5.93
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -6.32%
ROE -14.76%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 77.17%
FCFM N/A
ROA(3y)-9.79%
ROA(5y)-15.6%
ROE(3y)-36.93%
ROE(5y)-38.73%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.33%
GM growth 5Y-0.67%
F-Score2
Asset Turnover0.04
Health
Industry RankSector Rank
Debt/Equity 0.3
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 499.47%
Cap/Sales 141.6%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.46
Quick Ratio 0.45
Altman-Z -1.21
F-Score2
WACC6.96%
ROIC/WACCN/A
Cap/Depr(3y)946.67%
Cap/Depr(5y)661.42%
Cap/Sales(3y)292%
Cap/Sales(5y)220.5%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)25.49%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%12.08%
EPS Next Y52.28%
EPS Next 2Y33.16%
EPS Next 3Y9.98%
EPS Next 5Y12.58%
Revenue 1Y (TTM)-30.63%
Revenue growth 3Y-6.45%
Revenue growth 5Y8.15%
Sales Q2Q%-34.54%
Revenue Next Year106.79%
Revenue Next 2Y76.47%
Revenue Next 3Y59.71%
Revenue Next 5Y59.63%
EBIT growth 1Y-4.5%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year55.32%
EBIT Next 3Y34.06%
EBIT Next 5Y22.76%
FCF growth 1Y48.89%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y23.04%
OCF growth 3YN/A
OCF growth 5YN/A

AVANTIUM / AVTX.AS Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for AVANTIUM?

ChartMill assigns a fundamental rating of 2 / 10 to AVTX.AS.


What is the valuation status of AVANTIUM (AVTX.AS) stock?

ChartMill assigns a valuation rating of 0 / 10 to AVANTIUM (AVTX.AS). This can be considered as Overvalued.


Can you provide the profitability details for AVANTIUM?

AVANTIUM (AVTX.AS) has a profitability rating of 1 / 10.


What is the financial health of AVANTIUM (AVTX.AS) stock?

The financial health rating of AVANTIUM (AVTX.AS) is 2 / 10.